Literature DB >> 22192307

Kinetic tracking of therapy-induced senescence using the real-time cell analyzer single plate system.

Timo Weiland1, Alexander Berger, Frank Essmann, Ulrich M Lauer, Michael Bitzer, Sascha Venturelli.   

Abstract

In recent years, terminal growth arrest, that is, senescence, especially therapy-induced senescence (TIS), has become a major subject in cancer research and several fields of life sciences. Senescence is characterized by a specific set of morphological and biochemical changes. However, methods that evidence senescence induction are still very limited and show large variation between individual examiners. Most notably, these assays are classical endpoint assays, and, therefore, screening for senescence is time consuming and expensive. Here, we describe an efficient, simple, and objective method to screen for TIS over time by modifying the Real-Time Cell Analyzer SP system, thus enabling to pin point the induction of senescence. This method continuously detects the cell's impedance in each well of a 96-microwell plate that allows to observe increment of cell size, a hallmark feature of cellular senescence. This technique is suitable for high-throughput TIS screening by measuring several compounds, small molecules, and/or cell lines simultaneously.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22192307     DOI: 10.1089/adt.2011.0402

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  4 in total

1.  Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.

Authors:  Sascha Venturelli; Alexander Berger; Alexander Böcker; Christian Busch; Timo Weiland; Seema Noor; Christian Leischner; Sabine Schleicher; Mascha Mayer; Thomas S Weiss; Stephan C Bischoff; Ulrich M Lauer; Michael Bitzer
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

2.  Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma.

Authors:  Mascha Mayer; Alexander Berger; Christian Leischner; Olga Renner; Markus Burkard; Alexander Böcker; Seema Noor; Timo Weiland; Thomas S Weiss; Christian Busch; Ulrich M Lauer; Stephan C Bischoff; Sascha Venturelli
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01

3.  Epigenetic impacts of ascorbate on human metastatic melanoma cells.

Authors:  Sascha Venturelli; Tobias W Sinnberg; Alexander Berger; Seema Noor; Mitchell Paul Levesque; Alexander Böcker; Heike Niessner; Ulrich M Lauer; Michael Bitzer; Claus Garbe; Christian Busch
Journal:  Front Oncol       Date:  2014-08-25       Impact factor: 6.244

4.  Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy.

Authors:  Chihab Klose; Susanne Berchtold; Marina Schmidt; Julia Beil; Irina Smirnow; Sascha Venturelli; Markus Burkard; Rupert Handgretinger; Ulrich M Lauer
Journal:  BMC Cancer       Date:  2019-12-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.